OpenAlex
PricingAboutJobs
Log inGet started
Work

Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy

HTML

Year: 2016
Type: review
Source: Leukemia & lymphoma/Leukemia and lymphoma
DOI: 10.3109/10428194.2016.1161185
Authors: Maria-Elisabeth Goebeler, Ralf Bargou
Institutions: Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg
Language: English

Topic: Acute Lymphoblastic Leukemia research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: blinatumomab, bispecific T-cell engagers, B-cell malignancies, relapsed/refractory non-Hodgkin lymphoma, cytokine release syndrome, neurological adverse effects, T cell therapy, FDA approval
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2325329618
FWCI: 1.891
Cites: 66
Cited by: 187
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms